Pharmacological analysis of Empagliflozin: Acting through the CaMKII pathway in type 2 diabetes and acute cardiovascular events. Shao G. PLoS One 2022;17:e0270152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shao G. Pharmacological analysis of Empagliflozin: Acting through the CaMKII pathway in type 2 diabetes and acute cardiovascular events. PLoS One 2022;17:e0270152.
PMID: 35767566